Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3517149 | 0.84 | — | — | |
| SCHEMBL1177488 | 0.81 | — | — | |
| SCHEMBL1078274 | 0.81 | — | — | |
| SCHEMBL19549311 | 0.81 | TSHR (0.34) | — | |
| SCHEMBL10972293 | 0.78 | — | — | |
| SCHEMBL9442582 | 0.78 | — | — | |
| Hydrogen Sulfide SCHEMBL8530806 | 0.76 | — | — | |
| SCHEMBL1505284 | 0.75 | TSHR (0.42) | — | |
| SCHEMBL181106 | 0.75 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL15110455 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111565707-A | Devices and methods for delivering therapeutics | 森玛治疗公司 | 2020-08-21 | — | — | CN | claimed |
| JP-2009508852-A | — | — | 2009-03-05 | — | — | JP | claimed |
| EP-1973952-A1 | CONJUGATE COMPRISING PHARMACEUTICAL ACTIVE COMPOUND COVALENTLY BOUND TO MUCOADHESIVE POLYMER AND TRANSMUCOSAL DELIVERY METHOD OF PHARMACEUTICAL ACTIVE COMPOUND USING THE SAME | Gwangju Institute of Science and Technology (KR) | 2008-10-01 | — | — | EP | claimed |
| WO-2007083984-A1 | CONJUGATE COMPRISING PHARMACEUTICAL ACTIVE COMPOUND COVALENTLY BOUND TO MUCOADHESIVE POLYMER AND TRANSMUCOSAL DELIVERY METHOD OF PHARMACEUTICAL ACTIVE COMPOUND USING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2007-07-26 | — | — | WO | claimed |
| JP-3184999-A | — | — | None | — | — | JP | disclosed |
| US-20240192236-A1 | Compounds and Methods for Use in Detecting Gabapentin | ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT | 2024-06-13 | — | — | US | disclosed |
| US-11905323-B2 | Recombinant chimeric protein for selectins targeting | Bracco Suisse (CH) | 2024-02-20 | — | — | US | disclosed |
| US-11867705-B2 | Compounds and methods for use in detecting gabapentin | ARK DIAGNOSTICS, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| EP-4213943-A1 | COMPOSITIONS AND METHODS TARGETING FILAMENTOUS BACTERIOPHAGE | The University Of Montana (US) | 2023-07-26 | — | — | EP | disclosed |
| US-11525835-B2 | Compounds and methods for use in detecting gabapentin | ARK DIAGNOSTICS, INC. (US) | 2022-12-13 | — | — | US | disclosed |
| US-20220389080-A1 | RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING | BRACCO SUISSE SA (CH) | 2022-12-08 | — | — | US | disclosed |
| US-11370826-B2 | Recombinant chimeric protein for selectins targeting | BRACCO SUISSE SA (CH) | 2022-06-28 | — | — | US | disclosed |
| WO-1998028626-A9 | OPTIMIZATION OF GENE DELIVERY AND GENE DELIVERY SYSTEMS | — | 1998-10-29 | — | — | WO | disclosed |
| EP-0786087-A1 | POLYPEPTIDE-DENDRIMER COMPLEXES | DADE INTERNATIONAL INC. (US) | 1997-07-30 | — | — | EP | disclosed |
| US-5635157-A | RADIOIMMUNOASSAY | BROOKHAVEN SCIENCE ASSOCIATES | 1997-06-03 | — | — | US | disclosed |
| US-5607659-A | Directed biodistribution of radiolabelled biotin using carbohydrate polymers | NEORX CORPORATION (US) | 1997-03-04 | — | — | US | disclosed |
| WO-1997007398-A1 | POLYPEPTIDE-DENDRIMER COMPLEXES | DADE INTERNATIONAL INC. (US) | 1997-02-27 | — | — | WO | disclosed |
| US-5292938-A | Medical diagnosis; higher and more prolonged tumor uptake, lower retention in kidneys, bones and livers | ASSOCIATED UNIVERSITIES, INC. (US) | 1994-03-08 | — | — | US | disclosed |
| US-5095097-A | Diagnostics | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1992-03-10 | — | — | US | disclosed |
| JP-H03184999-A | MAGNETIC PROTEIN CONJUGATE, PREPARATION OF THE SAME | BEHRINGWERKE AG | 1991-08-12 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240192236-A1 | Compounds and Methods for Use in Detecting Gabapentin | GABRE, GABRG3, GABRB2 | TRPA1 2091/4885ALDH1A1 1863/4885 |
| US-11525835-B2 | Compounds and methods for use in detecting gabapentin | GABRE, GABRG3, GABRB2 | TRPA1 2091/4885ALDH1A1 1863/4885 |
| US-11905323-B2 | Recombinant chimeric protein for selectins targeting | SELPLG, SELL, SELE | TRPA1 3393/4885ALDH1A1 2114/4885 |
| US-20220389080-A1 | RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING | SELPLG, SELL, SELE | TRPA1 3393/4885ALDH1A1 2114/4885 |
| US-11867705-B2 | Compounds and methods for use in detecting gabapentin | GABRE, GABRG3, GABRB2 | TRPA1 2091/4885ALDH1A1 1863/4885 |
| US-11370826-B2 | Recombinant chimeric protein for selectins targeting | SELPLG, SELL, SELE | TRPA1 3393/4885ALDH1A1 2114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.